2021 American Transplant Congress » Kidney: Acute Cellular Rejection

Date & Time:
None. Available on demand

Location: Virtual

Session Type: Poster Abstract

Meeting: 2021 American Transplant Congress

Continuous 24-Hour Antithymocyte Globulin (ATG) for Renal Allograft Rejection: Results of a Randomized Controlled Trial

S. J. Patel, A. Rogers, S. Kuten, R. Knight, E. Graviss, D. Nguyen, T. Ellimuttil, I. Agboli, L. Gaber, A. Gaber
Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection

C. Patton, K. Cunningham, C. D'Agostino, A. Novak, M. Kapugi, K. Lang, C. Kane
How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?

F. Aziz¹, S. Parajuli², N. Garg², M. Mohamed², A. Djamali², D. Mandelbrot²
Impact of Induction Immunosuppression Selection on Clinical Outcomes in Kidney Transplant Recipients During the COVID-19 Pandemic in New York City

K. Khalil, S. Jonchhe, J. Stern, T. C. Lewis, N. Alnazari, B. Lonze, Z. Stewart Lewis, N. Ali
Impact of Treatment of Subclinical Rejection at 2 Weeks After Kidney Transplantation, Compared by 1 Year Histologic Outcomes

O. Lee¹, K. Lee¹, J. Park¹, J. Lee², G. Kwon³, K. Kim⁴
Kidney Transplant Survival After Borderline Rejection in the Setting of Denovo Dsa Formation

A. P. Bregman¹, S. Jackson², S. Riad¹
Role of Serial Donor Derived Cell-Free DNA Monitoring in Kidney Transplant Recipients

A. X. Wang, C. R. Lenihan

« View all sessions from the 2021 American Transplant Congress